期刊文献+

PCR-RFLP方法检测锰超氧化物歧化酶基因V(16)A多态性的实验条件研究 被引量:1

The Study of Conditions Influencing Polymerase Chain Reaction-restriction Fragment Length Polymorphism in the Site of Manganese Superoxide Dismutase Gene V(16)A Polymorphism
下载PDF
导出
摘要 目的:确定PCR-RFLP技术检测锰超氧化物歧化酶基因(MnSOD)V(16)A多态性的最适实验条件.方法:对影响MnSOD基因PCR反应以及用限制性内切酶BsawI切割主要因素进行了系统研究.结果:最适退火温度为55℃;最适引物浓度为0.25μmol/L;最适Mg2+浓度为1.5 mmol/L;最适dNTP浓度为0.20 mmol/L;以0.6 U为最适Taq酶量.酶切体系为15μL体系中加8μL产物用2 U的酶消化,为后续研究奠定了实验基础. Objective: To confirm the optimal test condition of the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in the site of manganese superoxide dismutase (MnSOD) gene V(16)A polymorphism. Methods: The factors influencing PCR-RFLP in the site of MnSOD gene V(16)A polymorphism were studied. Results: The results revealed the optimum conditions: annealing temperature was 55℃ ; primer concentration was 0.25 μmol/L; magnesium concentration was 1.5 rnmol/L; concentration of dNTP was 0.20 mmol/L; magnesium concentration was 1.5mmol/L; concentration of dNTP was 0.20 mmol/L; Taq enzyme was 0.6 U; the effective digestion system was 15μL including 8μL DNA solution and 2U enzyme. The information in this study may be useful to relative experiments.
出处 《昆明医学院学报》 2005年第4期15-20,共6页 Journal of Kunming Medical College
基金 云南省自然科学基金资助项目(2004C0066M) 云南省教育厅资助项目(04Z023C)
关键词 聚合酶链反应 限制性片段长度多态性 MnSOD基因 实验条件 Polymerase chain reaction Restriction fragment length polymorphism MnSOD gene Test condition
  • 相关文献

参考文献5

二级参考文献8

  • 1TAKASHI N, YASUSHI T, LIANSHAN P, et al.The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients [ J ]. J Hum Genet, 2003,48: 138.
  • 2CHISTYAKOV D A, SAVOST′ANOV K V, ZOTOVA E V, et al. Polymorphisms in the Mn- SOD and ECSOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus[J]. BMC Med Genet, 2001, 2:4.
  • 3COWIE C C, PORT F K, WOLFE R A, et al. Disparities in incidence of diabetic end - stage renal disease according to race and type of diabetes [ J ]. N Engl J Med, 1982, 321:1074.
  • 4DIABETES DRAFTING GROUP. Prevalence of small vessel and large vessel disease in diabetic patients from 14centres: the world health organization multinational study of vascular disease in diabetics[J]. Diabetologia, 1986,28 (Suppl): 615.
  • 5PARK J Y, KIM H K, CHUNG Y E, et al. Incidence and determinants of microalbuminuria in Koreanswith type 2 diabetes [J]. Diabetes Care, 1998,21 (4) 530.
  • 6VAN LANDEGHEM G F, TABATABAIE P,KUCINSKASV, et al. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD[J]. Hum Hered, 1999, 49:190.
  • 7HORI H, HARADA H, NISHI H, et al. Polymorphisms in the SOD2 and HLA- DRBi genes are associated with nonfamilial idiopathle dilated cardiomyopathy in Japanese[J].Biochem Biophys Res Commun, 1999, 261:332.
  • 8杨金奎,谌贻璞.糖尿病肾病诊治研究进展[J].基础医学与临床,2003,23(4):353-358. 被引量:20

共引文献28

同被引文献4

  • 1OSGOOD-MC W, GALLUZZI J R, ORDOVAS J M. Allelic Discrimination for Single Nucleotide Polymorphisms in the Human Scavenger Receptor Class B Type 1 Gene Locus Using Fluorescent Probes [ J ]. Clin Chem, 2000,46 (1):118-119
  • 2SEVALL J S. Rapid allelic discrimination from real-time DNA amplification[J ]. Methods,2001,25(4) :452 - 455
  • 3KWOK S, HIGUCHI R. Avoiding false positives with PCR[J]. Nature,339:237- 238
  • 4LIVAK K J,MARMARO J,TODD J A. Towards fully automated genome-wide polymorphism screening [J]. Genet, 1995,9 : 341 - 342

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部